DG

Devenkumar Gunvantrai Bharad

Active Director Director DIN 01441496
DIN 01441496 First appointment May 2011 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Devenkumar Gunvantrai Bharad

Data last updated:

Devenkumar Gunvantrai Bharad is a Director at Pediacare Pharma Private Limited (since 2011). The company operates in Pharma.

DIN 01441496
Primary Designation Director
Industry Pharma
First Appointment 02 May 2011
Oldest Company Age 15 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pediacare Pharma Private Limited U24239GJ2011PTC065241
Director02 May 20112011Active

Board colleagues of Devenkumar Gunvantrai Bharad

Directorship timeline

Open interactive timeline →
Pediacare Pharma Private Limited
Premium access

Shareholding and investment profile for Devenkumar Gunvantrai Bharad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devenkumar Gunvantrai Bharad

Devenkumar Gunvantrai Bharad currently holds 1 directorship: Pediacare Pharma Private Limited (Director, since 02 May 2011).

Devenkumar Gunvantrai Bharad was first appointed on 02 May 2011 as Director at Pediacare Pharma Private Limited.

The current boards of Devenkumar Gunvantrai Bharad's companies include Kaizar Sujauddin Kapasi (Pediacare Pharma Private Limited), Vishvachandra Dhirajlal Javiya (Pediacare Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available